Justin S. Keisel
Known title: EVP, President of Global SalesCIK: 0002014791
Associated companies
Transaction History
| NUS | ▲ Buy | Grant | 47,059 | $0 | 3/6/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 13,687 | $118K | 2/26/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 1,534 | $13K | 2/15/2026 | View on chart |
| NUS | ▲ Buy | Grant | 2,910 | $0 | 2/10/2026 | View on chart |
| NUS | ▲ Buy | Grant | 34,500 | $0 | 2/10/2026 | View on chart |
| NUS | ▼ Sell | Other | 48 | $357 | 3/5/2025 | View on chart |
| NUS | ▲ Buy | Grant | 51,747 | $0 | 2/26/2025 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 5,552 | $42K | 2/15/2025 | View on chart |
| NUS | ▲ Buy | Grant | 1,198 | $0 | 2/12/2025 | View on chart |
| NUS | ▼ Sell | Other | 47 | $358 | 12/11/2024 | View on chart |
| NUS | ▼ Sell | Other | 51 | $356 | 9/11/2024 | View on chart |
| NUS | ▼ Sell | Other | 27 | $355 | 6/12/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nu Skin: Turnaround Narrative Gains Attention
A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.
Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.